Category: Antibody Technologies
Antibody Technologies market research reports by GlobalData
-
Innovation Insights: Engineered Multispecific antibodies
Innovation Insights: Engineered Multispecific antibodies Summary Engineered multispecific antibodies (MsAbs) are innovative therapeutic molecules designed to bind simultaneously to multiple epitopes on the same or different targets. This capability allows them to address complex diseases more effect ... Read More
-
Innovation Insights: B-cell Depletion
Innovation Insights: B-cell Depletion Summary B cell depletion is a therapeutic strategy aimed at reducing the number of B lymphocytes, which play a crucial role in autoimmune diseases and certain cancers. This approach is primarily used to treat conditions like rheumatoid arthritis, multiple sclero ... Read More
-
Antibody-Drug Conjugates (ADC): Market Overview
Antibody-Drug Conjugates (ADC): Market Overview Summary Clients will gain insight into the competitive landscape of leading antibody-drug conjugates (ADC) in oncology including SWOT analysis for key marketed and pipeline drugs, clinical benchmark comparisons, key clinical trial analysis, analyst con ... Read More
-
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Inflammatory Disease Markers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and K ... Read More
-
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast ... Read More